10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Innovative Therapies and Drug Discovery
The future of treating infectious diseases lies in innovative therapies and drug discovery, where new scientific advancements are reshaping treatment landscapes. As drug resistance continues to rise and new pathogens emerge, the need for alternative therapeutic options has never been more critical. Researchers in the realm of innovative therapies and drug discovery are exploring a variety of methods, from developing small molecules that target bacterial resistance mechanisms to designing vaccines that can preemptively neutralize infections. Breakthroughs in biotechnology and molecular biology are making it possible to rapidly identify potential drug candidates and accelerate clinical trials. This progress holds the promise of more effective, efficient, and accessible treatments to address infectious diseases on a global scale.
Francis J Castellino
University of Notre Dame, United States
Ranjan Ramasamy
IDFISH Technology, United States
Saurabh Chattopadhyay
University of Kentucky College of Medicine, United States
Rico Leonardo Lizbinski
Northern Light Health, United States
Sasha Leibholz
New York Presbyterian Columbia/Cornell, United States
Lauren Gruffi
New York Presbyterian Columbia/Cornell, United States
Stephanie Maltais
University of Montreal, CanadaSubmit your abstract Today
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Mathematical modeling of COVID-19 dynamics in a West African context
Christabel Emaeyak James, University of Glasgow, United Kingdom
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan